1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc.

ORIC
ORIC Pharmaceuticals, Inc.US flagNASDAQ Global Select
10.83
USD
+0.41
- -
1.12BMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
22
29
49
79
87
111
143
143
+ Selling, General & Admin
3
6
13
22
25
26
29
33
+ Research & Development
19
23
36
57
62
85
114
110
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-22
-29
-49
-79
-87
-111
-143
-143
- Non-Operating (Income) Loss
-1
-2
24
- -
2
-10
-15
-14
+ Interest Expense, Net
-1
-1
- -
- -
-3
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
1
1
- -
- -
3
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
25
- -
5
-10
-15
-14
Pretax Income
-21
-27
-74
-79
-89
-101
-128
-129
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-21
-27
-74
-79
-89
-101
-128
-129
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-21
-27
-74
-79
-89
-101
-128
-129
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-21
-27
-74
-79
-89
-101
-128
-129
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-21
-27
-74
-79
-89
-101
-128
-129
EBIT
-22
-29
-49
-79
-87
-111
-143
-143
EBITDA
-21
-28
-48
-78
-86
-110
-142
-142
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
-22
-29
-49
-79
-87
-111
-143
-143
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
1
1
1
1
1
1
1
1
Basic Weighted Avg Shares
19
19
22
38
40
51
70
88
Basic EPS, GAAP
-1.12
-1.4
-3.36
-2.07
-2.25
-1.96
-1.83
-1.47
Basic EPS from Cont Ops
-1.12
-1.4
-3.36
-2.07
-2.25
-1.96
-1.83
-1.47
Diluted Weighted Avg Shares
19
19
22
38
40
51
70
88
Diluted EPS, GAAP
-1.12
-1.4
-3.36
-2.07
-2.25
-1.96
-1.83
-1.47
Diluted EPS from Cont Ops
-1.12
-1.4
-3.36
-2.07
-2.25
-1.96
-1.83
-1.47

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
44
90
297
241
210
213
262
288
+ Cash, Cash Equivalents & STI
43
89
294
237
206
208
256
281
+ Cash & Cash Equivalents
43
89
78
226
67
23
59
46
+ ST Investments
- -
- -
215
11
139
185
197
236
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
1
3
4
4
4
6
7
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
3
4
2
58
37
39
12
120
+ Property, Plant & Equip, Net
3
2
2
2
3
3
3
2
+ Property, Plant & Equip
5
6
6
7
9
9
10
10
- Accumulated Depreciation
3
4
4
5
6
6
7
8
+ LT Investments & Receivables
- -
- -
- -
43
22
27
- -
111
+ LT Investments
- -
- -
- -
43
22
27
- -
111
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
2
- -
12
12
10
9
7
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
2
- -
12
12
10
9
7
Total Assets
47
94
299
299
247
252
274
409
+ Payables & Accruals
1
2
5
8
7
11
14
9
+ Accounts Payable
- -
- -
1
2
1
1
2
4
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
2
4
7
6
10
12
5
+ ST Debt
- -
- -
- -
2
3
3
3
3
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
2
3
3
3
3
+ Other ST Liabilities
1
4
4
5
5
7
8
8
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
4
4
5
5
7
8
8
Total Current Liabilities
3
5
9
15
15
20
25
20
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
109
179
- -
11
9
7
6
4
+ Accrued Liabilities
1
1
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
107
178
- -
11
9
7
6
4
Total Noncurrent Liabilities
109
179
- -
11
9
7
6
4
Total Liabilities
111
184
9
26
25
28
31
25
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
3
456
518
558
659
806
1,076
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
3
456
518
558
659
806
1,076
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-66
-93
-166
-245
-334
-435
-563
-692
+ Other Equity
- -
- -
- -
- -
-1
- -
- -
1
Equity Before Minority Interest
-64
-90
290
273
222
224
243
384
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-64
-90
290
273
222
224
243
384
Total Liabilities & Equity
47
94
299
299
247
252
274
409
Shares Outstanding
28
28
37
39
45
55
71
99
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
2
3
3
3
3
Net Debt
-43
-89
-78
-226
-67
-23
-59
-46
Net Debt to Equity
66.18
98.97
-27.07
-82.79
-30.06
-10.44
-24.43
-11.88
Tangible Common Equity Ratio
-137.86
-95.74
96.92
91.41
89.96
88.92
88.68
94
Current Ratio
16.84
16.81
32.96
15.87
13.68
10.39
10.56
14.13
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-21
-27
-74
-79
-89
-101
-128
-129
+ Depreciation & Amortization
1
1
1
1
1
1
1
1
+ Non-Cash Items
- -
1
25
14
13
9
12
23
+ Stock-Based Compensation
- -
1
5
13
14
15
20
25
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
20
1
-1
-6
-8
-2
+ Chg in Non-Cash Work Cap
-1
1
2
4
- -
5
2
-5
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-2
1
1
2
- -
2
+ Inc (Dec) in Accts Payable
- -
1
4
3
-1
3
2
-7
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-21
-24
-45
-60
-75
-86
-113
-111
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-1
-1
-1
-2
-1
-1
-1
+ Acq of Fixed Prod Assets
-1
-1
-1
-1
-2
-1
-1
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
271
50
25
85
125
244
+ Increase in Capital Stock
- -
- -
271
50
25
85
125
244
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-215
159
-107
-43
23
-147
+ Dec in LT Investment
- -
- -
10
229
131
197
275
252
+ Inc in LT Investment
- -
- -
-225
-70
-238
-239
-252
-400
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
-1
-216
158
-109
-43
22
-148
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
38
71
-21
-1
- -
1
2
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
38
71
251
49
25
86
127
245
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
17
47
-11
148
-159
-43
36
-14
EBITDA
-21
-28
-48
-78
-86
-110
-142
-142
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-21
-24
-46
-60
-77
-87
-114
-112
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-24
-46
-60
-77
-87
-114
-112
Free Cash Flow per Basic Share
-1.11
-1.27
-2.09
-1.59
-1.95
-1.68
-1.63
-1.27
Price/Free Cash Flow
- -
- -
-16.65
-9.52
-3.2
-5.58
-5.05
-6.51
Cash Flow to Net Income
0.97
0.88
0.61
0.76
0.84
0.85
0.88
0.86
Capital Expenditures
-1
-1
-1
-1
-2
-1
-1
-1